Quantifying the association between Campylobacter infection and Guillain-Barré syndrome: a systematic review.
Guillain-Barré Syndrome (GBS) is a neurologic disease that causes ascending paralysis and is triggered by a preceding bacterial or viral infection. Several studies have shown that patients with GBS have a recent history of infection due to Campylobacter jejuni. A literature review of published studies that reported rates of Campylobacter infection before or in conjunction with GBS was done. These reported data were used for calculating the proportion of GBS cases who tested positive for Campylobacter compared to the control population and the incidence of GBS among patients infected with Campylobacter. Results of the analysis suggest that 31% of 2,502 GBS cases included in these papers are attributable to Campylobacter infection.
George Washington School of Medicine and Health Sciences, Washington, DC, USA.
Kate O
KO
Poropatich
Christa L Fischer
CL
Walker
Robert E
RE
Black
D002169:Campylobacter Infections / Q000150:complications*; D016123:Campylobacter jejuni; D016022:Case-Control Studies; D020275:Guillain-Barre Syndrome / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D015994:Incidence
Arch Neurol. 2007 Oct;64(10):1519-23
17923636
Ann Neurol. 1993 Aug;34(2):130-5
8338337
Ann Neurol. 1993 Mar;33(3):243-7
8498807
Ann Neurol. 1995 Nov;38(5):809-16
7486873
Trans R Soc Trop Med Hyg. 2004 Jun;98(6):342-6
15099989
J Endotoxin Res. 2000;6(5):341-59
11521055
Clin Microbiol Rev. 1998 Jul;11(3):555-67
9665983
Ann Neurol. 1999 Feb;45(2):168-73
9989618
Chin Med J (Engl). 1993 Nov;106(11):845-7
8143497
Neuroepidemiology. 1998;17(6):296-302
9890808
Clin Microbiol Infect. 2007 Mar;13(3):334-7
17391394
Med J Aust. 1987 Jul 6;147(1):13-6
3626926
Neuroepidemiology. 2009;32(2):150-63
19088488
Neurology. 1998 Oct;51(4):1110-5
9781538
J Infect. 1984 Jan;8(1):85-6
6699419
J Infect Dis. 2006 Jul 1;194(1):95-7
16741887
Ann Neurol. 1996 Aug;40(2):181-7
8773599
Am J Epidemiol. 2001 Mar 15;153(6):610-4
11257070
J Neuroimmunol. 1999 Dec;100(1-2):74-97
10695718
Brain. 1995 Jun;118 ( Pt 3):597-605
7600081
Clin Vaccine Immunol. 2006 Jul;13(7):779-83
16829615
J Clin Neurosci. 2009 Jun;16(6):733-41
19356935
Natl Med J India. 2006 May-Jun;19(3):137-9
16836263
Biomed Environ Sci. 2003 Jun;16(2):105-11
12964782
J Neuroimmunol. 1998 Jan;81(1-2):138-43
9521615
J Neuroimmunol. 1999 May 3;96(2):245-50
10337924
Ann Neurol. 1993 Aug;34(2):136-44
8338338
Indian J Pediatr. 2009 Aug;76(8):795-9
19381495
Q J Med. 1993 Feb;86(2):111-7
8464986
J Neurol Sci. 1999 Apr 1;164(2):134-8
10402024
Neurology. 2010 Feb 16;74(7):581-7
20157160
Ann Neurol. 1996 Oct;40(4):635-44
8871584
Ann Neurol. 1978 Jun;3(6):565-6
677829
PLoS One. 2008;3(11):e3674
19002255
Br Med J (Clin Res Ed). 1984 Jun 23;288(6434):1867-70
6428580
J Neuroimmunol. 1998 Jan;81(1-2):116-26
9521613
J Infect Dis. 1997 Dec;176 Suppl 2:S125-8
9396695
Ann Neurol. 1990;27 Suppl:S21-4
2194422
Ann Intern Med. 1993 Jun 15;118(12):947-53
8489109
Ann Neurol. 2000 Oct;48(4):624-31
11026446
Chin Med J (Engl). 1995 Apr;108(4):262-4
7789212
Ann Neurol. 1999 Nov;46(5):701-7
10553986
Symp Ser Soc Appl Microbiol. 2001;(30):145S-54S
11422570
J Infect Dis. 1997 Dec;176 Suppl 2:S129-34
9396696
Br Med J (Clin Res Ed). 1982 Jul 17;285(6336):173-4
6807396
Arch Dis Child. 1996 Apr;74(4):281-7
8669925